Invizyne’s Nasdaq IPO Marks New Era of Biomanufacturing
Underlying technology demonstrates the use of enhanced enzyme systems outside of cells can bypass many of the limitations ...
Yahoo Finance23 小时
Invizyne Technologies Begins Trading on NASDAQ
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based ...
Finanznachrichten22 小时
Invizyne Technologies, Inc.: Invizyne Technologies Begins Trading on NASDAQ
Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important molecules and ...
Invizyne Technologies, Inc.: Invizyne's Nasdaq IPO Marks New Era of Biomanufacturing
Today, Invizyne Technologies, Inc., (NASDAQ:IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based ...